Pharmaust finds buyer for CBI
Tuesday, 10 June, 2008
WA generic medicines company Pharmaust (ASX: PAA) has found a buyer for its share in Commonwealth Biotechnologies Inc (CBI), a US-based life sciences R&D outsourcing specialist.
In a statement, Pharmaust's board said it had decided that ownership of the shares was doing nothing to help the company's bottom line, but had run into difficulties selling the shares.
The shares were unregistered, meaning they could not be sold on the NASDAQ exchange and had to be sold privately.
The company has finally sourced a likely buyer, Hong Kong-based Venturepharm Laboratories.
Pharmaust shareholders will be asked to vote on the deal on July 11.
SEQ koala population carries immunity to retrovirus
Koalas from a population north of the Brisbane River appear to have evolved a unique genomic...
RSV immunisation program for babies slashes hospital stays
An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...
A targeted treatment option for psoriasis
New research from MedUni Vienna paves the way for the development of a therapy that not only...
